Concepedia

Michael F. Jarvis

MF

Statistics

Publications

188

Citations

13.9K

H-Index

62

Active since

1974

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

University of Glasgow

Novartis (Switzerland)

Michael F. Jarvis is an author at Abbott Fund specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1974–2023

188

Publications

188

Structure and properties of pectin gels in plant cell walls

Michael F. Jarvis · Plant Cell & Environment · 1984 · 572 citations

, , +16

[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Michael F. Jarvis, Richard Schulz, A. Hutchison et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 546 citations

A-803467, a potent and selective Na <sub>v</sub> 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 514 citations · Full text

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 458 citations · Full text

A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat

Prisca Honoré, Diana L. Donnelly‐Roberts, Marian T. Namovic et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 401 citations

Rows per page

1–5 of 188